Log In
Print this Print this

Omnaris, ciclesonide nasal spray

  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionCorticosteroid aerosol nasal formulation using hydrofluoroalkane (HFA)
Molecular Target Corticoid receptors
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationRhinitis
Indication DetailsTreat seasonal allergic rhinitis (SAR)
Regulatory Designation
Partner Sumitomo Dainippon Pharma Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today